Study number 778578
Dates
Jan 11 2026-Mar 04 2026
Location
Dallas, Texas
Age
18-55
Gender
Men and Women
Smoker
No
Compensation
$16,903
Group
3
This is a research study for an investigational drug being developed for the treatment of skin, joint, digestive, and other conditions where the immune system does not work correctly.
Dallas, TX is currently recruiting Healthy Adults, Ages 18-55
Refer a friend & receive $400 per qualified referral
Women Eligibility Criteria
Body Mass Index
Smoking criteria
Screening procedures
C3
Check-in: Jan 11, 25, Feb 5, 19
Check-out: Jan 18, 31, Feb 11, 25,
Follow- up visit: Mar 4